Results for Thrombolytic Therapy

Publications & Outputs

1. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

   Sandercock, P., Wardlaw, J. M., Lindley, R. I., Dennis, M., Cohen, G., Murray, G., Innes, K., Venables, G., Czlonkowska, A., Kobayashi, A., Ricci, S., Murray, V., Berge, E., Slot, K. B., Hankey, G. J., Correia, M., Peeters, A., Matz, K., Lyrer, P., Gubitz, G., & 4 othersPhillips, S. J., Arauz, A., Emsley, H. & IST-3 collaborative group, 23/06/2012, In: The Lancet. 379, 9834, p. 2352-2363 12 p.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review

2. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited

   Sandercock, P., Lindley, R., Wardlaw, J., Dennis, M., Innes, K., Cohen, G., Whiteley, W., Perry, D., Soosay, V., Buchanan, D., Venables, G., Czlonkowska, A., Kobayashi, A., Berge, E., Slot, K. B., Murray, V., Peeters, A., Hankey, G. J., Matz, K., Brainin, M., & 11 othersRicci, S., Cantisani, T. A., Gubitz, G., Phillips, S. J., Antonio, A., Correia, M., Lyrer, P., Kane, I., Lundstrom, E., Emsley, H. & IST-3 collaborative group, 30/11/2011, In: Trials. 12, 9 p., 252.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review